ClinConnect ClinConnect Logo
Search / Trial NCT06575244

The Effects of the Community-based Sailing Programme in Enhancing Resilience of School-aged Children with Autism: a Pilot Randomised Controlled Study

Launched by CHINESE UNIVERSITY OF HONG KONG · Aug 26, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Autism Spectrum Disorder Children Sailing Quality Of Life Resilience Nature Based Intervention

ClinConnect Summary

This clinical trial is exploring whether a community-based sailing program can help improve the resilience and overall well-being of school-aged children with autism. The researchers want to see if taking part in sailing activities can enhance the children's quality of life, self-esteem, and social skills, and reduce feelings of depression. To find out, they will compare the effects of the sailing program with a control group that receives different attention but does not go sailing.

To be eligible for this study, children must be between 7 and 12 years old, have a confirmed diagnosis of autism, and be enrolled in a school that supports inclusive education. They also need to be able to communicate and complete questionnaires in Chinese. Over four days, participants will join in sailing sessions for a total of 16 hours. It’s important to note that children with prior sailing experience or severe motion sickness will not be included in the trial. This is a great opportunity for children to engage in a new activity while potentially gaining valuable skills and experiences!

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. be between the ages of 7 and 12,
  • 2. have a confirmed diagnosis of ASD,
  • 3. be enrolled in inclusive education school,
  • 4. possess the ability to complete the questionnaire in Chinese,
  • 5. be able to communicate in Chinese.
  • Exclusion Criteria:
  • With sailing experience,
  • With a history of severe motion sickness symptoms.

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Myrian Sze Nga Fan, MSc

Principal Investigator

Chinese University of Hong Kong

William Ho Cheung Li, PhD

Study Chair

Chinese University of Hong Kong

Laurie Long Kwan Ho, PhD

Study Director

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported